betnovate RD cream 100g
betnovate RD cream 100g

Betnovate RD 0.025% Cream/Ointment

From: £22.49

Betnovate RD is a topical corticosteroid preparation used to treat eczema. It contains a medication called betamethasone valerate, which helps to treat swelling, itching and irritation of the skin. It is available as a cream and ointment in a pack size of 100 grams.

Please note: This treatment is currently out of stock through our service. You can view other treatments we offer for eczema here.

Is this the best treatment for you?

Complete an online consultation (can be completed in 60 seconds!) to determine a suitable treatment.

Go to treatments to start a consultation

FREE Royal Mail
1st Class Delivery

You will need to complete an online consultation for us to determine a suitable treatment.

Go to treatments to start a consultation

    Betnovate RD contains betamethasone valerate at a strength of 0.025% w/v.

    Betamethasone valerate is considered a potent corticosteroid, however Betnovate RD contains betamethasone valerate in a lower concentration than Betnovate.

    ‘RD’ stands for ‘Ready Diluted’ meaning it contains less of the active ingredient and is used for milder skin problems or to help keep your skin problems under control after Betnovate has improved it.

    It is used to treat moderate eczema and can also be used to treat other conditions such as psoriasis and dermatitis. 


    Please always follow the medical advice provided or read the patient information leaflet provided with Betnovate RD cream and Betnovate RD ointment

    Betnovate RD should be applied once or twice a day and you should reduce the dose as your skin begins to get better. 

    When applying Betnovate RD you should:

    • Wash and dry your hands before applying it 
    • Spread the cream or ointment, thinly over the area of irritated skin 
    • It should be carefully smoothed into the skin, in the direction that your hair grows
    • It should not be applied to broken skin or cuts
    • You should wash your hands afterwards, unless you are treating your hand


    • Keep out of the sight and reach of children.
    • Do not use this medicine after the expiry date which is stated on the tube end or carton after (EXP) – The expiry date refers to the last day of that month.
    • Do not store above 25°C

    You should not use Betnovate RD cream or Betnovate RD ointment if you are allergic to betamethasone valerate or any of the ingredients. Betnovate RD Cream contains chlorocresol which may cause allergic reactions and cetostearyl alcohol which may cause local skin reactions e.g. contact dermatitis. 

    Topical steroid creams such as Betnovate RD (betamethasone valerate 0.025%) cream and ointment can make certain skin conditions worse, including acne, rosacea, perioral dermatitis (a rash around the mouth), itchy skin which is not inflamed, or infected skin.  

    As with all medications, Betnovate RD can cause certain side effects although not everyone will experience them. You should seek medical attention if you experience blurred vision or other visual disturbances whilst on this medication. 

    Please note: steroid skin creams can dry onto your clothes and bedding making them more likely to catch fire so you should avoid naked flames.

    For more information regarding the cautions, warning and potential side effects please read Betnovate RD cream and Betnovate RD ointment patient information leaflet.

    You can find more information about Betnovate RD (betamethasone valerate 0.025%) cream and ointment in the patient information leaflet provided with the medication. An example of a patient information for Betnovate RD 0.025% cream can be found here. For more information on eczema, please visit our eczema condition page.

Although all of our content is written and reviewed by healthcare professionals, it should not be substituted for or used as medical advice. If you have any questions about your health, please speak to your doctor.

Authored Oct 07, 2021 by Joseph Issac, MPharm
Reviewed May 14, 2022 by Prabjeet Saundh, MPharm